Read Secondary Schizophrenia Online
Authors: Perminder S. Sachdev
neuronal storage disorders that
withdrawal,
121
synaptic pruning,
312
present with psychosis in
diagnosis, criteria for,
116–
19
adulthood,
215t
clinical description,
116
syphilis,
394
Niemann-Pick Disease type C,
217,
common neural substrate,
systemic lupus erythematosus (SLE),
TACTICS MDs USE,
10t
histamine H2 receptor,
182
incidence of TBI,
186
tactile exam,
52
opioids/nonsteroidal anti-
secondary auditory hallucinations
inflammatory drugs,
182
tactile hallucinations,
266
epidemiology,
180
trifluoperazine,
87
tardivelike dyskinesia (TD),
51,
395
future research,
183
general etiological factor,
180–
1
trigeminal/facial corneal reflex,
49
Tatetsu, S.,
128
general risk factors,
180
Trimble, M. R.,
105
Tay Sach’s Disease (TSD),
215t
,
216
implications for clinical practice,
trinucleotide repeat disorders,
352t
Teggin, A. F.,
32
management,
183
Tucker, G. J.,
382
Tellenbach, H.,
104
pathogenesis of drug-induced,
183
Turner Syndrome,
313
temporal association, in SZ,
9,
17
secondary tactile hallucinations,
34
secondary visual hallucinations,
TXB1,
319
temporal lobe epilepsy (TLE),
80,
394
summary/conclusions,
183
ubiquitin fusion degradation I gene,
temporomandibular joint dysfunction,
toxoplasmosis,
281
Ueda, Y.,
236
tertiary syphilis,
394
tramadol,
370
UFD1L,
319
tetrahydrocannabinol (THC),
169,
transcranial magnetic stimulation
Ujike, H.,
134
(TMS),
133
Umbricht, D.,
84
δ
-9-tetrahydrocannabinol,
114
transient tinnitus,
29
tetrathiomolybdate,
340
transmission disequilibrium test
unilateral tinnutus,
29
thalamo-cortical dissociations,
66
(TDT),
291
uniparental disomy (UPD),
328,
thalamus,
183
traumatic brain injury (TBI),
association with
thioridazine,
87
schizophrenia-like
US Drug Abuse Warning Network
Thomeer, E. C.,
234
psychosis (SLP)
(DAWN),
142
US National Epidemiological
pulsatile,
29
Catchment Area study,
187
transient,
29
birth trauma and schizophrenia,
Utena, H.,
130
unilateral,
29
course,
191
Todd’s paralysis,
84
diagnostic criteria,
191
Tomiyama, C.,
130
head injury characteristics,
190–
1
psychopathology,
191
relationship with epilepsy,
192–
3
topiramate,
87
risk factors and pathophysiology,
varying movement disorder,
218
Tourette’s Syndrome,
396
pre-existing vulnerability,
192
toxic psychosis (delirium),
120
specific neuroanatomical
Veith, G.,
94
in amphetamine abusers,
130
velocardiofacial syndrome (VCFS),
53
specific underlying cognitive
facial features, typical,
310,
311f
delirium/dementia/psychosis
syndrome,
192
features warrant testing in
characteristics,
181t
sex differences,
190
schizophrenia patient,
310t
DSM-IV diagnostic criteria for
conclusions,
193
ideogram of chromosome 22,
317f
commonly used drugs as cause,
181,
molecular genetics related to
risk factors for schizophrenia
following TBI,
189
studies examining association
PRODH,
318
anticonvulsants,
182
mouse models,
318
antidepressants,
182
TXB1,
319
antiemetics,
182
UFD1L,
319
antiparkinsonians,
182
cross-sectional surveys,
187
antipsychotics,
182
benzodiazepines,
182
implications for medicolegal
corticosteroids,
182
sensorimotor gating,
320
velocardiofacial syndrome (cont.)
irritative,
372
neurodevelopmental hypothesis of
palinopsia,
370
mechanisms for psychosis,
photopsias,
370
abnormalities prior to onset,
312
release,
372
structural brain abnormalities at
trigger factors in,
370
onset,
312
visual auras,
370
neurological features,
341
visual word form area (VWFA),
pathology of,
338
premorbid neuropsychological and
pathophysiology of,
338
brain morphometric
psychiatric features,
341
vitamin E,
335
psychiatric diagnoses in
Vogels, A.,
329
psychological abnormalities in
volumetric intercorrelations,
63,
66
child,
313
von Meduna, L.,
103
quantitative MRI studies in child,
voxel-based morphometry (VBM),
6,
Wimmer, A.,
381
structural brain abnormalities,
Winder, R.,
64
Wisconsin Card Sorting Test,
349
prevalence in schizophrenia,
313
Walterfang, M.,
267
quantitative MRI studies in adults,
Wechsler Memory Scale,
207
Witton, J.,
120
schizophrenia phenotype,
315
Weinberger, D. R.,
7
schizophrenia risk for person with,
Weinberger, L. M.,
374
Wolfram Disease,
236
treatment of VCFS-associated
Weiser, M.,
120
working memory
psychiatric illnesses,
316
Wernicke’s area,
30
fMRI study,
5
ventral stream,
25
Wernicke’s Syndrome, alcohol-related,
ketamine effect on,
146
Ventral Tegmental Area (VTA),
106,
Wortis, J.,
60
West, C.,
24
ventricular volume increases,
6
Westphal variant, of Huntington’s
Verdoux, H.,
173
Disease,
349
xenon inhalation method,
61
Verhoeven, W. M.,
329
Whitman, B. Y.,
329
Xiao, J.,
198
very long chain fatty acids (VLCFA),
WHO schizophrenia study,
175
Wicker, B.,
373
Yamazaki, M.,
233
vigabatrin,
87
Younger, J.,
329
violence risk, in substance-induced
Wilson’s Disease (WD)
psychosis,
122
antipsychotics for,
399
visual auras,
370
basal ganglia role in,
359
Zammit, S.,
171
visual exam, for schizophrenia,
51